CH564020A5 - - Google Patents

Info

Publication number
CH564020A5
CH564020A5 CH1899770A CH1899770A CH564020A5 CH 564020 A5 CH564020 A5 CH 564020A5 CH 1899770 A CH1899770 A CH 1899770A CH 1899770 A CH1899770 A CH 1899770A CH 564020 A5 CH564020 A5 CH 564020A5
Authority
CH
Switzerland
Application number
CH1899770A
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CH1699770A priority Critical patent/CH513455A/fr
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of CH564020A5 publication Critical patent/CH564020A5/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CH1899770A 1969-12-23 1970-12-22 CH564020A5 (cs)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CH1699770A CH513455A (fr) 1970-12-22 1970-11-18 Colifichet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6271169 1969-12-23

Publications (1)

Publication Number Publication Date
CH564020A5 true CH564020A5 (cs) 1975-07-15

Family

ID=10488412

Family Applications (1)

Application Number Title Priority Date Filing Date
CH1899770A CH564020A5 (cs) 1969-12-23 1970-12-22

Country Status (13)

Country Link
US (1) US3741959A (cs)
JP (1) JPS4946637B1 (cs)
AT (1) AT318139B (cs)
BE (1) BE760683A (cs)
CA (1) CA918655A (cs)
CH (1) CH564020A5 (cs)
DE (1) DE2063268C2 (cs)
DK (1) DK136217B (cs)
ES (1) ES386741A1 (cs)
FR (1) FR2074139A5 (cs)
GB (1) GB1332306A (cs)
NL (1) NL167165C (cs)
SE (1) SE400560B (cs)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2265798C2 (de) * 1971-06-24 1985-09-26 Fujisawa Pharmaceutical Co., Ltd., Osaka Verfahren zur Herstellung von Oxoazetidin-Derivaten
US3994912A (en) * 1971-07-08 1976-11-30 E. R. Squibb & Sons, Inc. 1-Oxides of Schiff bases of 6-aminopenicillanic acid
BE791160A (fr) * 1972-01-03 1973-05-09 Beecham Group Ltd Nouveaux cephemes substitues
US3965098A (en) * 1972-11-29 1976-06-22 American Home Products Corporation Intermediates for preparing cephalosporins and methods of production
US4051131A (en) * 1972-11-29 1977-09-27 American Home Products Corporation (Del.) Intermediates for preparing cephalosporins
US4203992A (en) * 1978-12-11 1980-05-20 E. R. Squibb & Sons, Inc. β-Bromopenicillanic acid sulfone
US4203993A (en) * 1978-12-11 1980-05-20 E. R. Squibb & Sons, Inc. 6α-Bromopenicillanic acid sulfone
US4420426A (en) * 1979-03-05 1983-12-13 Pfizer Inc. 6-Alpha-halopenicillanic acid 1,1-dioxides
US4714761A (en) * 1979-03-05 1987-12-22 Pfizer Inc. 6,6-dihalopenicillanic acid 1,1-dioxides and process
US4223135A (en) * 1979-03-19 1980-09-16 Bristol-Myers Company Production of cephalosporins
US4316017A (en) * 1979-03-19 1982-02-16 Bristol-Myers Company Cephalosporin intermediates
US4316016A (en) * 1979-03-19 1982-02-16 Bristol-Myers Company Cephalosporin intermediates
US4248780A (en) * 1979-08-21 1981-02-03 Canada Packers Limited Process for preparing ampicillin
US4432970A (en) * 1979-11-23 1984-02-21 Pfizer Inc. 6-beta-Halopenicillanic acid 1,1-dioxides as beta-lactamase inhibitors
ATE248835T1 (de) * 1999-06-25 2003-09-15 Vertex Pharma Prodrugs von impdh-inhibierenden carbamaten

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB991586A (en) * 1963-02-28 1965-05-12 Beecham Res Lab Process for the preparation of penicillins
FR1432427A (fr) * 1964-05-15 1966-03-18 Bayer Ag Procédé de préparation de produits de polycondensation
GB1104937A (en) * 1964-05-28 1968-03-06 Glaxo Lab Ltd Improvements in or relating to the acylation of 7-aminocephalosporanic acid and derivatives thereof
US3507861A (en) * 1966-09-14 1970-04-21 Lilly Co Eli Certain 3-methyl-cephalosporin compounds
US3351597A (en) * 1966-11-23 1967-11-07 Lilly Co Eli Process for acylating 7-amino cephalosporanic acid
US3478018A (en) * 1967-10-02 1969-11-11 American Home Prod Process for producing alpha-amino penicillins

Also Published As

Publication number Publication date
DK136217B (da) 1977-09-05
AT318139B (de) 1974-09-25
DE2063268C2 (de) 1983-04-14
ES386741A1 (es) 1973-03-16
CA918655A (en) 1973-01-09
GB1332306A (en) 1973-10-03
JPS4946637B1 (cs) 1974-12-11
SE400560B (sv) 1978-04-03
NL7018626A (cs) 1971-06-25
NL167165C (nl) 1981-11-16
FR2074139A5 (cs) 1971-10-01
DK136217C (cs) 1978-02-06
DE2063268A1 (de) 1971-07-08
BE760683A (cs) 1971-06-22
US3741959A (en) 1973-06-26

Similar Documents

Publication Publication Date Title
AU2270770A (cs)
DK136217C (cs)
AU429630B2 (cs)
CS152356B2 (cs)
CS149914B2 (cs)
AU2355770A (cs)
AU427401B2 (cs)
AU428074B2 (cs)
AU410358B2 (cs)
AU417208B2 (cs)
AU442322B2 (cs)
AU442463B2 (cs)
AU442535B2 (cs)
AT308690B (cs)
AU428131B2 (cs)
AU425297B2 (cs)
AU438128B2 (cs)
AU428129B2 (cs)
AU414607B2 (cs)
AR203167Q (cs)
AU1036070A (cs)
AU436893A (cs)
BE742775A (cs)
BE741705A (cs)
BE741370A (cs)

Legal Events

Date Code Title Description
PFA Name/firm changed

Owner name: GLAXO OPERATIONS UK LIMITED

PL Patent ceased